Steve Gens of Gens & Associates discusses how a renewed focus on affiliate operations can contribute to resolving data gaps and eliminate inefficiencies within the processes.
Peter Freed, Head of Global Pharma Customer Technical Support at Roquette breaks open mannitol, the mighty molecule, and takes a closer look at some of its underrepresented functionalities.
Whether it’s cost-of-goods or build-versus-buy analysis, eXmoor Pharma’s Harvey Branton, Evelien Stalmeijer and Ruxandra Comisel say a clear understanding of the end goal is key to develop predictive models for cell and gene therapy manufacturing.
The U.S. Food and Drug Administration (FDA) and the Medicines and Healthcare products Regulatory Agency have approved Eli Lilly and Company's Zepbound (Mounjaro) (tirzepatide) injection
The European Commission’s revision of its Good Manufacturing Practices (GMP) Annex 1 for sterile drug products will have implications for pharmaceutical companies that market their sterile drug products in the EU.
This article explores how starting materials, specifically producer cell lines and the design of transfer plasmids, affect the quality attributes of AAV vectors.
Stanley Capital Partners announces its portfolio company, Laboratoire X.O, has completed the acquisition of the prescription drug Nimodipine under the brand name Nimotop from Bayer for several markets globally excluding mainland China.
As 2023 draws to a close and companies finalise their Regulatory and Quality budgets for 2024, Arriello’s Kate Coleman assesses the trends topping the strategic agenda.
Julie Neal, Director at management consultancy, Vendigital, and Dr. Ulli Waltinger, Vice President specialising in AI and IoT at Siemens Advanta explore Life Sciences: A Data-Led Approach to Sustainability Transformation.
